International Stroke Conference 2025  /  Fast and Furious: Stroke in the Real World - Addressing Challenges In Acute Stroke Management  /  Pro: Andexanet alfa is Preferred over PCC for Reversal of FXa Inhibitor Associated ICH
Logo

American Heart Association

  52
  0

Final ID:

Pro: Andexanet alfa is Preferred over PCC for Reversal of FXa Inhibitor Associated ICH

  • Shoamanesh, Ashkan  ( MCMASTER UNIVERSITY , Hamilton , Ontario , Canada )
  • Goldstein, Joshua  ( MASSACHUSETTS GENERAL HOSPITAL , Lynnfield , Massachusetts , United States )
  • Christensen, Hanne  ( BISPEBJERG HOSPITAL , Copenhagen Nv , Denmark )
  • Seiffge, David  ( Inselspital , Bern , Switzerland )
  • Siegal, Deborah  ( University of Ottawa , Ottawa , Ontario , Canada )
    • Author Disclosures:
    Ashkan Shoamanesh: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Daiichi Sankyo:Active (exists now) ; Consultant:Bioxides:Past (completed) ; Speaker:Bayer AG:Active (exists now) ; Speaker:Daiichi Sankyo:Active (exists now) ; Speaker:AstraZeneca:Active (exists now) ; Consultant:Bayer AG:Active (exists now) ; Consultant:Daiichi Sankyo:Active (exists now) | Joshua Goldstein: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Consultant:NControl:Past (completed) ; Consultant:Pfizer:Past (completed) ; Individual Stocks/Stock Options:Cayuga:Active (exists now) ; Consultant:Takeda:Active (exists now) ; Consultant:CSL Behring:Past (completed) ; Consultant:Octapharma:Active (exists now) | Hanne Christensen: DO have relevant financial relationships ; Researcher:ANNEXA-I trial Astra-Zeneca:Active (exists now) | David Seiffge: DO NOT have relevant financial relationships | Deborah Siegal: No Answer
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Fast and Furious: Stroke in the Real World - Addressing Challenges In Acute Stroke Management

Tuesday, 02/04/2025 , 08:30AM - 05:00PM

Pre-Con Symposium – Stroke in the Real World

More abstracts on this topic:
Debate: IVT beyond 4.5h Should Not Be Implemented in Primary Stroke

Gordon Perue Gillian


Debate: Mobile Stroke Units Are Ready For Prime Time, And You Are Failing Your Patients If You Are Not Using Them

Grotta James, Alexandrov Anne

More abstracts from these authors:
Antithrombotic treatment in ICH: Perspectives from Vascular Neurology

Shoamanesh Ashkan, Al-shahi Salman Rustam

Emerging Antithrombotic Options for Stroke Prevention

Shoamanesh Ashkan

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)